YaoGeJu

Company directoryChina company filings

Anhui Welman Pharmaceutical Co.,Ltd.

As of 18 November 2026, for the company name Anhui Welman Pharmaceutical Co.,Ltd. as recorded, the chemical-drug catalogue lists 15 active records with this name as holder; 9 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/18
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.

Drug filings

21 acceptance records as first applicant, grouped into 13 source drug names. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

复方鱼腥草软胶囊 · No verified English name 2 records · Latest accepted 2026/09/28

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2604968Supplement2026/09/28Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗
CYZB2501699Supplement2025/08/07Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗
Diphenhydramine Hydrochloride Injection 1 records · Latest accepted 2026/06/25

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601497Generic2026/06/25Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗
Aztreonam For Injection 1 records · Latest accepted 2025/07/12

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2550256Supplement2025/07/12Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗
Ethyl Iosapentate Capsules 1 records · Latest accepted 2025/05/21

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501837Generic2025/05/21Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗
Morinidazole and Sodium Chloride Injection 1 records · Latest accepted 2025/03/05

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500921Generic2025/03/05Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗
Vecuronium Bromide For Injection 1 records · Latest accepted 2025/01/01

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2450651Supplement2025/01/01Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗
Citicoline Sodium Injection 1 records · Latest accepted 2024/09/25

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2450490Supplement2024/09/25Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗
Ceftazidime And Avibactam Sodium For Injection 1 records · Latest accepted 2024/04/26

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2401277Generic2024/04/26Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗
Ceftazidime for Injection 3 records · Latest accepted 2024/03/06

Supplement · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2450174Supplement2024/03/06Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗
CYHB2450173Supplement2024/03/06Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗
CYHB2450172Supplement2024/03/06Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗
Cefoperazone Sodium and Sulbactam Sodium for Injection 2 records · Latest accepted 2024/03/06

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2450179Supplement2024/03/06Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗
CYHB2350857Supplement2023/11/21Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗
注射用头孢唑肟钠 · No verified English name 2 records · Latest accepted 2023/12/25

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2303597Generic2023/12/25Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗
CYHS2303596Generic2023/12/25Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗
Cefazolin Sodium for Injection 2 records · Latest accepted 2022/12/31

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2250785Supplement2022/12/31Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗
CYHB2240037Supplement2022/10/21Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗
Cefotaxime Sodium For Injection 3 records · Latest accepted 2022/12/30

Supplement · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2250781Supplement2022/12/30Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗
CYHB2250780Supplement2022/12/30Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗
CYHB2250779Supplement2022/12/30Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗

Changes in the last 90 days

2 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Marketing application approved: 1 applicationAccepted: 1 application

  1. 2026/11/03Marketing application approved

    Morinidazole and Sodium Chloride Injection

    CYHS2500921 · 国药准字H20266458

    Fact date: 2026/11/03 · Publication date: 2026/11/05 · Date added to this site: 2026/11/06

    View source · Table row 33 ↗
  2. 2026/09/28Accepted

    复方鱼腥草软胶囊 · No verified English name

    CYZB2604968

    Fact date: 2026/09/28 · Date added to this site: 2026/10/22

    View source ↗

Under review

4 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
复方鱼腥草软胶囊 · No verified English name CYZB2604968Supplement2026/09/28Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗
Diphenhydramine Hydrochloride Injection CYHS2601497Generic2026/06/25Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗
复方鱼腥草软胶囊 · No verified English name CYZB2501699Supplement2025/08/07Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗
Ethyl Iosapentate Capsules CYHS2501837Generic2025/05/21Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗

Catalogue holder records

15 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Aztreonam For InjectionAnhui Welman Pharmaceutical Co.,Ltd.Anhui Welman Pharmaceutical Co.,Ltd.国药准字H200738232026/08/26Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Vecuronium Bromide For InjectionAnhui Welman Pharmaceutical Co.,Ltd.Anhui Welman Pharmaceutical Co.,Ltd.国药准字H200845392026/02/25Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Citicoline Sodium InjectionAnhui Welman Pharmaceutical Co.,Ltd.Anhui Welman Pharmaceutical Co.,Ltd.国药准字H200555882025/09/09Drug that passed quality-and-efficacy consistency evaluationCDE ↗
注射用头孢唑肟钠 · No verified English nameAnhui Welman Pharmaceutical Co.,Ltd.Anhui Welman Pharmaceutical Co.,Ltd.国药准字H202539142025/04/15Generic approved under the new chemical-drug registration classificationCDE ↗
注射用头孢唑肟钠 · No verified English nameAnhui Welman Pharmaceutical Co.,Ltd.Anhui Welman Pharmaceutical Co.,Ltd.国药准字H202539132025/04/15Generic approved under the new chemical-drug registration classificationCDE ↗
Ceftazidime for InjectionAnhui Welman Pharmaceutical Co.,Ltd.Anhui Welman Pharmaceutical Co.,Ltd.国药准字H202580642025/04/10Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Ceftazidime for InjectionAnhui Welman Pharmaceutical Co.,Ltd.Anhui Welman Pharmaceutical Co.,Ltd.国药准字H200134022025/04/10Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefoperazone Sodium and Sulbactam Sodium for InjectionAnhui Welman Pharmaceutical Co.,Ltd.Anhui Welman Pharmaceutical Co.,Ltd.国药准字H202580562025/04/07Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefoperazone Sodium and Sulbactam Sodium for InjectionAnhui Welman Pharmaceutical Co.,Ltd.Anhui Welman Pharmaceutical Co.,Ltd.国药准字H200650122024/12/23Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefazolin Sodium for InjectionAnhui Welman Pharmaceutical Co.,Ltd.Anhui Welman Pharmaceutical Co.,Ltd.国药准字H340200972024/04/03Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefotaxime Sodium For InjectionAnhui Welman Pharmaceutical Co.,Ltd.Anhui Welman Pharmaceutical Co.,Ltd.国药准字H340219862023/12/26Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefotaxime Sodium For InjectionAnhui Welman Pharmaceutical Co.,Ltd.Anhui Welman Pharmaceutical Co.,Ltd.国药准字H202371842023/12/26Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefotaxime Sodium For InjectionAnhui Welman Pharmaceutical Co.,Ltd.Anhui Welman Pharmaceutical Co.,Ltd.国药准字H200133692023/12/26Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Ceftazidime And Avibactam Sodium For InjectionAnhui Welman Pharmaceutical Co.,Ltd.Anhui Welman Pharmaceutical Co.,Ltd.国药准字H202554482025/09/09Generic approved under the new chemical-drug registration classificationCDE ↗
Ceftazidime for InjectionAnhui Welman Pharmaceutical Co.,Ltd.Anhui Welman Pharmaceutical Co.,Ltd.国药准字H200134012025/04/10Drug that passed quality-and-efficacy consistency evaluationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

9 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.

NameCompany / applicantRegistration numberStatusSource update dateView source
维生素K1 · No verified English nameAnhui Welman Pharmaceutical Co.,Ltd.Y20230000958A2025/04/30CDE ↗
阿维巴坦钠 · No verified English nameAnhui Welman Pharmaceutical Co.,Ltd.Y20230000916A2025/04/01CDE ↗
盐酸苯海拉明 · No verified English nameAnhui Welman Pharmaceutical Co.,Ltd.Y20210000548A2023/09/15CDE ↗
维库溴铵 · No verified English nameAnhui Welman Pharmaceutical Co.,Ltd.Y20190007423A2023/10/31CDE ↗
环索奈德 · No verified English nameAnhui Welman Pharmaceutical Co.,Ltd.Y20190007031A2023/03/24CDE ↗
盐酸丙帕他莫 · No verified English nameAnhui Welman Pharmaceutical Co.,Ltd.Y20190006335A2025/12/02CDE ↗
泛酸钠 · No verified English nameAnhui Welman Pharmaceutical Co.,Ltd.Y20190004577A2025/04/18CDE ↗
甲磺酸罗哌卡因 · No verified English nameAnhui Welman Pharmaceutical Co.,Ltd.Y20190003733A2025/04/18CDE ↗
依达拉奉 · No verified English nameAnhui Welman Pharmaceutical Co.,Ltd.Y20170000325A2024/02/28CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

2 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Diprophylline Injection CYHS2503961Generic2025/11/14Da Wei (Anhui) Pharma Co., Ltd. romanized; Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗
维生素K滴剂 · No verified English name CYHS2500817Generic2025/02/22Hefei Ke Da Bio Technology Co., Ltd. romanized; Anhui Welman Pharmaceutical Co.,Ltd.CDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/18 · Current coverage may be incomplete
Chemical-drug catalogue
Last successful update: 2026/11/18
API registrations
Last successful update: 2026/11/18
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.